Research In Brief
This article was originally published in The Gray Sheet
New findings on deep brain stimulation, ischemic stroke devices, orthopedics and more.
You may also be interested in...
Second Sight Medical Products gains FDA panel endorsement for humanitarian device exemption approval of Argus II, which would be the first artificial retina available to restore vision to the blind.
A humanitarian device exemption application submitted by Second Sight Medical Products for its Argus II retinal prosthesis system will be considered by FDA’s Ophthalmic Devices Panel.
Clot removal device gains 510(k) clearance earlier than expected, will compete with Stryker’s Merci clot retrieval system.